Can obstructive sleep apnea trigger red-cell production and affect cognition?

Obstructive sleep apnea (OSA) produces recurrent airway obstruction with intermittent nocturnal hypoxemia/reoxygenation. This exposure plausibly links OSA both to modest hematologic adaptation and to cognitive vulnerability, although the clinical consequences differ substantially in frequency and certainty.

Hematologic effects

• Hypoxemia can activate erythropoietin (EPO)-mediated erythropoiesis. Across nine studies (407 participants), EPO was higher in OSA than control populations (standardized mean difference 0.61), though individual responses varied.
• Oxygen-desaturation burden—not apnea–hypopnea index alone—more consistently predicts hematologic effects. Lower nocturnal saturation and greater hypoxic exposure correlate with reticulocyte and polycythemia-related measures.
• Clinically significant secondary polycythemia remains uncommon: meta-analysis of 3,654 patients estimated prevalence at 2% overall, 2% in mild-to-moderate OSA, and 6% in severe OSA. A veteran cohort found erythrocytosis in 1.6% overall; even with moderate-to-severe OSA and nocturnal hypoxemia, prevalence was 8%.
• CPAP is associated with modest reductions in hemoglobin (~3.76 g/L) and hematocrit (~1.1 percentage points), consistent with a reversible hypoxia-related contribution.

Cognitive and mechanistic implications

• In prospective data from older women, greater oxygen-desaturation burden predicted incident mild cognitive impairment or dementia, with adjusted odds ratios approximately 1.7–2.3; sleep fragmentation was not associated with these outcomes.
• Recurrent hypoxemia/reoxygenation may promote oxidative stress, sympathetic activation, endothelial and blood–brain-barrier dysfunction, impaired cerebral perfusion, and neuroinflammation. These pathways provide a coherent mechanism for cumulative brain injury.
• Cognitive effects are contributory rather than deterministic; randomized CPAP trials have shown mixed, generally modest and domain-specific cognitive benefits.

Bottom line

• OSA-related nocturnal hypoxemia can stimulate EPO-linked red-cell production and plausibly contribute to cognitive impairment, especially with substantial oxygen desaturation. However, marked erythrocytosis should not be attributed to OSA without assessing other causes, including polycythemia vera, smoking/carboxyhemoglobinemia, pulmonary disease, and testosterone exposure.